Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.51 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.51 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.48 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.42 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | RRM1 | P23921 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL856465 | 1.00 | GNAI3 (0.51) | GNAI3GNAO1GNAI1GSRDPP7 | |
| Hydrochloric Acid SCHEMBL9537364 | 0.98 | GNAI3 (0.50) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL721692 | 0.98 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL14935740 | 0.98 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GSRDPP7 | |
| Hydrochloric Acid SCHEMBL10580924 | 0.98 | GNAI3 (0.50) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL722145 | 0.98 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GSRDPP7 | |
| Hydrochloric Acid SCHEMBL6428766 | 0.97 | GNAI3 (0.53) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL6840704 | 0.95 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL367556 | 0.95 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL855574 | 0.95 | NOD1 (0.47) | GNAI3GNAO1GNAI1GSRDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720322-A2 | ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE | BASF SE (DE) | 2026-04-08 | — | — | EP | claimed |
| WO-2024245141-A9 | ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE | BASF SE (DE) | 2025-02-06 | — | — | WO | claimed |
| WO-2024245141-A2 | ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE | BASF SE (DE) | 2024-12-05 | — | — | WO | claimed |
| EP-4720322-A2 | ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE | BASF SE (DE) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024245141-A9 | ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE | BASF SE (DE) | 2025-02-06 | — | — | WO | disclosed |
| WO-2024245141-A2 | ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE | BASF SE (DE) | 2024-12-05 | — | — | WO | disclosed |
| EP-3795561-B1 | METHOD FOR PRODUCING CARBAMATE AND METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2024-11-06 | — | — | EP | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| CN-114514012-B | External preparation for skin | 株式会社高丝 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-20060155021-A1 | Coating compositions containing rheology control agents | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-07-13 | — | — | US | disclosed |
| US-20060155146-A1 | Rheology control agents | AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) | 2006-07-13 | — | — | US | disclosed |
| CN-1056619-C | Peptides having activity as platelet aggregation inhibitors, pharmaceutical compositions containing them and their use | NIPPON STEEL CORP (JP) | 2000-09-20 | — | — | CN | disclosed |
| EP-0765307-A1 | N ALPHA-2-(4-NITROPHENULSULFONYL)ETHOXYCARBONYL-AMINO ACIDS | Hyundai Pharm. Ind. Co., Ltd. (KR) | 1997-04-02 | — | — | EP | disclosed |
| CN-1132515-A | Novel peptide, active as inhibitors of platelet aggregation | NIPPON STEEL CORP (JP) | 1996-10-02 | — | — | CN | disclosed |
| WO-1996025394-A1 | Nα-2-(4-NITROPHENULSULFONYL)ETHOXYCARBONYL-AMINO ACIDS | HYUNDAI PHARM. IND. CO., LTD. (KR) | 1996-08-22 | — | — | WO | disclosed |
| US-4835248-A | Biologically degradable polyamide for depot preparations having controlled release of the active compound | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-05-30 | — | — | US | disclosed |
| US-4296095-A | SALTS OF LYSINE ESTERS | BEIERSDORF AKTIENGESELLSCHAFT (DE) | 1981-10-20 | — | — | US | disclosed |
| US-3969087-A | Gels of nonpolar liquids with N-acyl amino acids and derivatives thereof as gelling agents | AJINOMOTO CO., LTD. (JA) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060155146-A1 | Rheology control agents | HCRTR1, HCRTR2, REL | GNAI3 4090/4885GNAO1 2725/4885GNAI1 4434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.